Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma
Annals of Allergy, Asthma, and Immunology, 04/04/2012Anderson WJ et al.
Overweight patients with persistent asthma may have attenuated symptom and fractional exhaled nitric oxide (FeNO) dose responses to inhaled budesonide compared with normal weight patients with asthma, with no differences in forced expiratory volume in 1 second (FEV1) or methacholine PC20 between groups. Attenuated cortisol suppression in the overweight group may be the clue to this difference, alluding to reduced peripheral lung deposition or absorption in overweight patients with asthma.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.